glucoză 100 mg ml 100 mg/ml soluţie perfuzabilă
ncpc international corp. - glucoza - soluţie perfuzabilă - 100 mg/ml
acesol-jurabek soluţie perfuzabilă
jurabek laboratories Îm srl - natrii acetas+natrii chloridum+amoxicillinum chloridum - soluţie perfuzabilă
acesol-jurabek soluţie perfuzabilă
jurabek laboratories Îm srl - combinaţie - soluţie perfuzabilă
glypressin 0,12 mg/ml
ferring-lÉciva, a.s - republica ceha - terlipressinum - sol. inj. - 0,12mg/ml - hormoni ai lobului posterior hipofizar hormon antidiuretic (adh) si analogi
noradrenalina kabi 1 mg/ml
labesfal-laboratorios almiro, s.a. - portugalia - noradrenalinum - conc. pt. sol. perf. - 1mg/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice
gnak 50 mg/ml
bieffe-medital s.a. - spania - combinatii - sol. perf. - 50mg/ml - solutii pentru administrare intravenoasa solutii implicate in balanta hidroelectrolitica (b05xa)
noradrenalina kalceks 1 mg/ml
as kalceks - letonia - noradrenalinum - conc. pt. sol. perf. - 1mg/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - agenți antineoplazici - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
lunsumio
roche registration gmbh - mosunetuzumab - limfom, folicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
noradrenalina sun 0,5 mg/ml
sun pharmaceutical industries europe b.v. - olanda - noradrenalinum - sol. perf. in seringa preumpluta - 0,5mg/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice